880 related articles for article (PubMed ID: 9435414)
1. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
2. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.
Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K
Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550
[TBL] [Abstract][Full Text] [Related]
3. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
[TBL] [Abstract][Full Text] [Related]
5. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.
Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK
Thyroidology; 1989 Dec; 1(3):109-14. PubMed ID: 2484872
[TBL] [Abstract][Full Text] [Related]
6. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Mori K; Hori H; Abe K
J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700
[TBL] [Abstract][Full Text] [Related]
7. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
8. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Choo YK; Yoo WS; Kim DW; Chung HK
Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
[TBL] [Abstract][Full Text] [Related]
10. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
12. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063
[TBL] [Abstract][Full Text] [Related]
13. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
14. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
[TBL] [Abstract][Full Text] [Related]
15. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
16. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease.
Michelangeli VP; Poon C; Topliss DJ; Colman PG
Thyroid; 1995 Jun; 5(3):171-6. PubMed ID: 7580264
[TBL] [Abstract][Full Text] [Related]
17. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.
Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK
Korean J Intern Med; 1990 Jan; 5(1):51-7. PubMed ID: 1980206
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
[TBL] [Abstract][Full Text] [Related]
19. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.
McLachlan SM; Rapoport B
Thyroid; 2013 Jan; 23(1):14-24. PubMed ID: 23025526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
